BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33621600)

  • 21. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy.
    Kim HS; Lee KS; Koh WJ; Jeon K; Lee EJ; Kang H; Ahn J
    Radiology; 2012 Apr; 263(1):260-70. PubMed ID: 22371609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clofazimine in
    Pinapala A; Koh LJ; Ng KH; Tambyah PA; Yap HK
    Perit Dial Int; 2021 Jan; 41(1):104-109. PubMed ID: 32148178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The analysis of species identification and susceptibility testing of Mycobacterium abscessus].
    Nie W; Duan H; Huang H; Lu Y; Chu N
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):517-21. PubMed ID: 25262693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical characteristics of 42 patients with different subspecies of
    He SQ; Chen PR; Chen H
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1228-1232. PubMed ID: 38044050
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient].
    Prevotat A; Bonne S; Veziris N; Senneville E; Yazdanpanah Y; Legout L
    Med Mal Infect; 2011 Aug; 41(8):446-8. PubMed ID: 21435808
    [No Abstract]   [Full Text] [Related]  

  • 27. Mycobacterial genotypes are associated with clinical manifestation and progression of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense.
    Shin SJ; Choi GE; Cho SN; Woo SY; Jeong BH; Jeon K; Koh WJ
    Clin Infect Dis; 2013 Jul; 57(1):32-9. PubMed ID: 23511298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea.
    Kim SY; Kim CK; Bae IK; Jeong SH; Yim JJ; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Kang YA
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):107-11. PubMed ID: 25467784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.
    Choi H; Kim SY; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin S; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.
    Henriette Zweijpfenning SM; Chiron R; Essink S; Schildkraut J; Akkerman OW; Aliberti S; Altenburg J; Arets B; van Braeckel E; Delaere B; Gohy S; Haarman E; Lorent N; McKew G; Morgan L; Wagner D; van Ingen J; Hoefsloot W
    Chest; 2022 Jul; 162(1):76-81. PubMed ID: 35063454
    [No Abstract]   [Full Text] [Related]  

  • 31. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
    Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
    BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Shen Y; Wang X; Jin J; Wu J; Zhang X; Chen J; Zhang W
    Biomed Res Int; 2018; 2018():4902941. PubMed ID: 30687747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.
    Roux AL; Catherinot E; Soismier N; Heym B; Bellis G; Lemonnier L; Chiron R; Fauroux B; Le Bourgeois M; Munck A; Pin I; Sermet I; Gutierrez C; Véziris N; Jarlier V; Cambau E; Herrmann JL; Guillemot D; Gaillard JL;
    J Cyst Fibros; 2015 Jan; 14(1):63-9. PubMed ID: 25085077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
    Liu Y; Tan Y; Islam MM; Cao Y; Lu X; Zeng S; Hameed HMA; Zhou P; Cai X; Wang S; Mugweru JN; Zhang G; Yin H; Liu J; Nuermberger E; Zhang T
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843996
    [No Abstract]   [Full Text] [Related]  

  • 35. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand.
    Ananta P; Kham-Ngam I; Chetchotisakd P; Chaimanee P; Reechaipichitkul W; Namwat W; Lulitanond V; Faksri K
    PLoS One; 2018; 13(11):e0208053. PubMed ID: 30496270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan.
    Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
    J Med Microbiol; 2018 Jan; 67(1):74-82. PubMed ID: 29227218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease.
    Kim DH; Kim BG; Kim SY; Huh HJ; Lee NY; Koh WJ; Kim H; Kwon OJ; Jhun BW
    J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of rapidly growing mycobacterial infections.
    Kasperbauer SH; De Groote MA
    Clin Chest Med; 2015 Mar; 36(1):67-78. PubMed ID: 25676520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.